|
|
Post by lifebreath on Aug 10, 2019 20:02:30 GMT -5
I wonder how many phases will be required? |
|
|
|
Post by Omega on Aug 10, 2019 20:10:49 GMT -5
Estimated Study Start Date : August 2019 Estimated Primary Completion Date : May 2020 Estimated Study Completion Date : August 2020 |
|
|
|
Post by agedhippie on Aug 10, 2019 21:51:50 GMT -5
I wonder how many phases will be required? According to the 10K that should be it. There is a PK trial, but that can easily be done in parallel and should be short. |
|
|
|
Post by lifebreath on Aug 10, 2019 22:23:28 GMT -5
I wonder how many phases will be required? According to the 10K that should be it. There is a PK trial, but that can easily be done in parallel and should be short. thanks I had remembered one trial, but the way the fda has treated techno. I had some doubts |
|
|
|
Post by lifebreath on Aug 10, 2019 22:24:41 GMT -5
Estimated Study Start Date : August 2019 Estimated Primary Completion Date : May 2020 Estimated Study Completion Date : August 2020 thanks |
|
|
|
Post by sayhey24 on Aug 11, 2019 6:44:20 GMT -5
According to the 10K that should be it. There is a PK trial, but that can easily be done in parallel and should be short. thanks I had remembered one trial, but the way the fda has treated techno. I had some doubts As Aged said this should be the long pole in the tent, the safety study. Since Technosphere is a well beaten horse when it comes to safety this should be a formality. |
|
paul
Researcher
Posts: 134
|
Post by paul on Aug 11, 2019 7:07:50 GMT -5
thanks I had remembered one trial, but the way the fda has treated techno. I had some doubts As Aged said this should be the long pole in the tent, the safety study. Since Technosphere is a well beaten horse when it comes to safety this should be a formality. In one of his comments, Spencer Osborne says, "UTHR plans 2 phase 3 trials. The first just got started." What does the second involve? |
|
|
|
Post by sayhey24 on Aug 11, 2019 7:31:03 GMT -5
PK profiling would be a reasonable guess which could use some of the safety participants.
|
|
|
|
Post by Clement on Aug 11, 2019 7:46:37 GMT -5
It might be that we get a few more details on Tuesday?? "Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 2019 Wedbush PacGrow Healthcare Conference in New York City. The presentation will take place on Tuesday, August 13, 2019, at 10:20 AM Eastern Time" finance.yahoo.com/news/united-therapeutics-corporation-present-2019-100000414.html |
|
